May 8, 2018 / 11:17 AM / in 5 months

BRIEF-Proteostasis Announces Formation Of Independent Steering Committee To Advise On Global Phase 3 Clinical Development Program For Pti-428 In Cystic Fibrosis

May 8 (Reuters) - Proteostasis Therapeutics Inc:

* PROTEOSTASIS ANNOUNCES FORMATION OF INDEPENDENT STEERING COMMITTEE OF LEADING EXPERTS TO ADVISE ON THE GLOBAL PHASE 3 CLINICAL DEVELOPMENT PROGRAM FOR PTI-428 IN CYSTIC FIBROSIS

* PROTEOSTASIS THERAPEUTICS INC - STEERING COMMITTEE WILL ADVISE ON DESIGN AND IMPLEMENTATION OF PHASE 3 GLOBAL CLINICAL PROGRAM FOR PTI-428 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below